104 studies found for:    Fabry Disease
Show Display Options
Rank Status Study
21 Recruiting Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
22 Completed PET Scans in Normal Volunteers and Patients With Fabry Disease
Conditions: Fabry Disease;   Healthy
Intervention:
23 Completed Alpha-Galactosidase A Replacement Therapy for Fabry Disease
Condition: Fabry Disease
Intervention: Drug: DRX005B
24 Unknown  Pulmonary Disease and Exercise Tolerance in Boys With Fabry Disease
Condition: Fabry Disease
Intervention:
25 Completed Data Collection in Women With Fabry Disease
Condition: Fabry Disease
Intervention:
26 Completed An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
27 Completed
Has Results
Dosing Study of Replagal in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
28 Recruiting Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: migalastat HCl 150 mg
29 Completed Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
Condition: Fabry Disease
Intervention:
30 Completed Replagal Enzyme Replacement Therapy for Adults With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: Replagal (Agalsidase Alfa);   Drug: Replagal
31 Completed Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
32 Recruiting Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation
Conditions: Fabry Disease;   Cerebrovascular Accident
Intervention: Other: No intervention
33 Unknown  Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers
Conditions: Fabry Disease, Cardiac Variant;   Right Ventricular Hypertrophy
Intervention:
34 Unknown  Viennese Prevalence Study of Anderson-Fabry Disease
Conditions: Fabry Disease;   Left Ventricular Hypertrophy
Intervention:
35 Completed Open Label Long-term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study
Condition: Fabry Disease
Intervention: Drug: AT1001
36 Recruiting Physician Initiated Request for Migalastat in Individual Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: migalastat HCl
37 Withdrawn Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease
Conditions: Fabry Disease;   Neuropathic Pain
Interventions: Drug: Gabapentin;   Drug: placebo
38 Completed Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy
Condition: Focus of Study: Prevalence of Fabry Disease in CKD Population
Intervention:
39 Completed
Has Results
Replagal Enzyme Replacement Therapy for Children With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Agalsidase alfa
40 Completed Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: migalastat hydrochloride;   Biological: agalsidase

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years